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Abstract
Vitamin D has been linked to various cardiovascular risk factors including indices of large-vessel disease. However, it remains unclear
whether vitamin D is also associated with microvascular damage. In a community-dwelling population, we studied associations
between vitamin D serum levels and retinal microvascular damage deﬁned as retinopathy signs, narrower arterioles, and wider
venules.
From the population-based Rotterdam Study, we included 5675 participants (age ≥45 years) with vitamin D data and gradable
retinal photographs. Serum levels of vitamin D were measured using an antibody-based assay. Retinal exudates, microaneurysms,
cotton wool spots, and dot/blot hemorrhages were graded on fundus photographs by experienced graders in the whole sample;
retinal vascular calibers, that is, arteriolar and venular diameters, were semiautomatically measured in a subsample (n=2973). We
examined the cross-sectional association between vitamin D and retinal microvascular damage using logistic and linear regression
models, adjusting for age, sex, and cardiovascular risk factors.
We found that persons with lower vitamin D levels were more likely to have retinopathy (adjusted odds ratio per standard deviation
(SD) decrease of vitamin D=1.30; 95% conﬁdence interval (CI): =1.12–1.49). Furthermore, lower vitamin D levels were associated
with wider venular calibers (adjustedmean difference per SD decrease in vitamin D=1.35; 95%CI=0.64–2.06). This association was
strongest among men (P for interaction=0.023).
Lower levels of vitamin D are associated with retinal microvascular damage, suggesting that the link with cardiovascular risk may
partly run through changes in the microvasculature.
Abbreviations: CI = conﬁdence interval, CVD = cardiovascular disease, RS = Rotterdam Study, SD = standard deviation.
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11. Introduction
Over the past decades, vitamin D deﬁciency has emerged as a
potentially modiﬁable risk factor for cardiovascular disease
(CVD).[1] The exact mechanisms for how vitamin D relates to
CVD are uncertain, but existing data show a strong link between
vitamin D and cardiovascular risk factors, which themselves
contribute to the development of CVD. In particular, population-
based studies have primarily focused on the relation of vitamin D
with various indices of large-vessel disease such as atherosclero-
sis,[2] arterial stiffness,[3] and arterial stenosis.[4] Together with
traditional cardiovascular risk factors, large-vessel disease
explains about 60% of the variance of incident CVD.[5] Yet, a
growing body of evidence shows that microvascular disease is
also an important contributor to the development of CVD.[6]
Retinal imaging provides a great opportunity to study the
microvasculature in vivo, and retinal microvascular damage—
assessed as retinopathy signs, arteriolar narrowing, and venular
widening—has been widely used as markers of microvascular
disease.[7] As such, studies have related these markers to incident
hypertension,[8] stroke,[9] and coronary heart disease,[10] sup-
porting the notion of a microvascular component in CVD.[11] In
view of these observations, we hypothesize that vitamin D could
be linked to CVD through the presence of a microvascular
component. Studies investigating the link between vitamin D and
indices of microvascular disease have shown that vitamin D
deﬁciency was associated with poor coronary microcircula-
tion,[12] endothelial dysfunction,[13] nephropathy,[14] and with
markers of cerebral small-vessel disease.[15] Although these
Mutlu et al. Medicine (2016) 95:49 Medicinestudies suggest a microvascular component in the link of vitamin
D with CVD, no study has investigated the direct relation of
vitamin D with markers of microvascular damage in humans. In
this study, we investigated associations between vitamin D and
direct visualization of microvascular damage using retinal
imaging in a community-dwelling population.Figure 1. Fundus photographs showing (A) signs of retinopathy and (B)
measurements of retinal vascular calibers. In (A), white arrow=small
hemorrhages; black arrow=hard exudates. In (B), red lines=arteriolar calibers;
blue lines=venular calibers.2. Methods
2.1. Setting and study population
This study was performed as part of the Rotterdam Study (RS), a
prospective population-based cohort study.[16] All inhabitants of
the Ommoord district in the city of Rotterdam, the Netherlands,
aged ≥55 years were invited to the study in 1990 (RS-I, n=7932)
and 2000 (RS-II, n=3011). In 2006, a further extension of the
cohort was initiated and participants aged 45 years or older were
invited (RS-III, n=3932). Vitamin D was measured in RS-II and
RS-III. Signs of retinopathy were graded on fundus photographs
in both cohorts, and retinal vascular calibers were measured only
in RS-III. In total, data on vitamin D were available in 5918
persons. Of these 5918 persons, 243 persons had no (gradable)
fundus photographs centered on the macula, or did not undergo
ophthalmic examinations. Thus, data on both vitamin D and
retinopathy were available in 5675 persons. In RS-III, data on
vitamin D were available in 3445 persons. Of these, 472 had no
(gradable) fundus photographs centered on the optic disc, or did
not undergo ophthalmic examinations, resulting in 2973 persons
with complete data on vitamin D and retinal vascular calibers.
Baseline home interviews and examinations were performed in
each cohort. The RS has been approved by the medical ethics
committee according to the Population Study Act: Rotterdam
Study, executed by theMinistry of Health,Welfare, and Sports of
the Netherlands. A written informed consent was obtained from
all participants.2.2. Assessment of 25-hydroxyvitamin D
Plasma levels of 25-hydroxyvitamin D were measured once in non-
fasting status using an electrochemiluminescense-based assay
(Elecsys Vitamin D Total, Roche Diagnostics, Mannheim,
Germany). This assay has a functional sensitivity of 10nmol/L
with 18.5% coefﬁcient of variation for intra-assay analyses. The
repeatability is given by the within-run precision of6.5% and the
reproducibility by the intermediate precision of11.5%.[1] Vitamin
D deﬁciency was considered as a level lower than 50nmol/L.2.3. Assessment of retinopathy signs
Participants underwent a full eye examination of both eyes
including fundus photography centered on the macula (35° ﬁeld,
Topcon TRV-50VT, Tokyo Optical Co., Tokyo, Japan) and
fundus photography centered on the optic disc (20° visual ﬁeld,
Topcon TRC-50VT, Tokyo Optical Co., Tokyo, Japan) after
pharmacological mydriasis on both eyes. Fundus photographs
were checked for quality and the presence of age-related
maculopathy by 2 experienced graders. These graders, each
having 20 years of experience, divided their work and graded all
fundus photographs particularly focusing on fundus signs of age-
related maculopathy. Consensus sessions and between-grader
comparisons were performed regularly, and weighted k coef-
ﬁcients ranged from 0.58 to 0.80 for various fundus lesions.
Retinopathy was deﬁned as the presence of one or more dot/blot2hemorrhages, microaneurysms, hard exudates, cotton wool
spots, or evidence of laser treatment for retinopathy in 1 eye
(Figure 1A). Retinopathy was also considered to be present in
participants with central retinal artery or vein occlusion.
2.4. Assessment of retinal vascular calibers
Retinal vascular calibers were measured in RS-III on fundus
photographs centered on the optic disc (Figure 1B). For each
participant, the image of 1 eye with the best quality was analyzed
with a semiautomated system (IVAN, University of Wisconsin-
Madison,Madison,WI), and 1 summary value was calculated for
the arteriolar calibers (in mm) and 1 for the venular calibers (in
mm).[17] As eyes may have different magniﬁcation due to
refractive changes, we adjusted vessel measurements for possible
magniﬁcation variations with Littmann formula to approximate
absolute measures.[18] We veriﬁed in a random subsample of 100
participants that individual measurements in the left and right eye
were similar. Measurements were performed by 1 rater, masked
for participant characteristics. Pearson correlation coefﬁcients for
interrater and intrarater agreement (n=100) were 0.85 and 0.86
for arteriolar calibers, and 0.87 and 0.87 for venular calibers,
respectively.2.5. Assessment of other measurements
Blood pressure was measured twice in sitting position at the right
brachial artery with a random-zero sphygmomanometer. We
used the average of 2 readings for analysis. We deﬁned
hypertension as a systolic blood pressure of 140 mm Hg or
more, a diastolic blood pressure of 90 mm Hg or more, use of
antihypertensive medication, or any combination of these 3
factors. Body mass index was computed as weight divided by
height squared. Non-fasting serum total and high-density
lipoprotein cholesterol concentrations were determined by an
automated enzymatic procedure.[19] Diabetes mellitus was
considered to be present if participants reported use of
antidiabetic medication or when fasting serum glucose level
was ≥7.0mmol/L. Serum levels of C-reactive protein were
determined by the Rate Near Infrared Particle Immunoassay
method (Immage® high-sensitive CRP, Beckman Coulter Inc.,
Brea, CA). Atherosclerotic plaques were assessed by ultrasound
at the carotid artery bifurcation, common carotid artery, and
internal carotid artery on both sides. Presence of plaques were
deﬁned as focal thickening of the vessel wall of at least 2mm
relative to adjacent segments with or without calciﬁed compo-
nents at any site. Information on smoking (never, former, or
Table 1
Characteristics of the study population.
Descriptive
Characteristic
Retinopathy signs
(RS-II and RS-III)
Retinal vascular
calibers (RS-III only)
Sample size, N 5675 2973
Age, y 60.1 (8.1) 56.8 (6.5)
Female sex, % 3,157 (56) 1,784 (57)
Systolic blood pressure, mm Hg 137.2 (20.8) 132.4 (18.8)
Diastolic blood pressure, mm Hg 81.2 (11.1) 82.5 (10.9)
Antihypertensive medication, % 1,558 (28) 787 (27)
Lipid-lowering medication, % 1,059 (19) 670 (23)
Body mass index, kg/m2 27.5 (4.4) 27.7 (4.6)
Total cholesterol, mmol/L 5.6 (1.0) 5.6 (1.1)
HDL cholesterol, mmol/L 1.4 (0.4) 1.4 (0.4)
Diabetes mellitus type 2, % 555 (10) 247 (8)
C-reactive protein, mg/L 2.5 (4.6) 2.6 (4.5)
Mutlu et al. Medicine (2016) 95:49 www.md-journal.comcurrent), antihypertensive and lipid-lowering medication use, and
vitamin D supplement use was obtained during the home
interview by a computerized questionnaire. Dietary intake data
were collected using a semiquantitative 389-item food-frequency
questionnaire. Vitamin D intake from foods was calculated using
the Dutch Food Composition Table of 2006. Prevalent CVD was
assessed as a history of myocardial infarction, coronary artery
bypass graft, percutaneous coronary intervention, coronary
revascularization, or stroke. An extensive description on
deﬁnitions of cardiovascular outcomes has been described
previously.[20,21] Kidney function was assessed by calculating
an estimated glomerular ﬁltration rate for serum creatinine and
cystatin combined, according to the Chronic Kidney Disease
Epidemiology Collaboration formula.[22] An estimated glomeru-
lar ﬁltration rate <60mL/min/1.73m2 was considered as having
kidney disease.Carotid plaque, % 2,936 (52) 1,046 (35)
Current smoker, % 1,223 (22) 679 (23)
eGFR, mL/min/1.73 m2 84.0 (14.7) 86.2 (13.7)
Vitamin D, nmol/L 60.8 (28.1) 60.2 (27.6)
Retinopathy signs, % 264 (5) 87 (3)
Arteriolar caliber, mm NA 158.4 (15.5)
Venular caliber, mm NA 239.6 (22.8)
Values are presented as means (standard deviation) or as numbers (percentages).
eGFR=estimated glomerular ﬁltration rate, HDL=high-density lipoprotein, NA=not applicable, RS=
Rotterdam Study.2.6. Statistical analyses
We standardized vitamin D values by creating z-scores
(individual value minus population mean, divided by the
standard deviation (SD)). In addition, we categorized participants
into quartiles on the basis of vitamin D levels. We assessed
associations of vitamin D with retinopathy using logistic
regression models and with retinal vascular calibers using linear
regression models. In model 1, we adjusted for age, sex, season
when the blood was drawn, the other vascular caliber
(if applicable), and subcohort (if applicable). In model 2, we
additionally adjusted for the following cardiovascular risk
factors: systolic blood pressure, diastolic blood pressure, use of
antihypertensive and lipid-lowering medication, body mass
index, total cholesterol, high-density lipoprotein cholesterol,
C-reactive protein, and smoking. As the use of vitamin D
supplements could inﬂuence these associations, we repeated our
analyses after adjusting for use of any vitamin supplements, and
again after excluding these persons. We explored effect
modiﬁcation by stratifying for sex, history of CVD, hypertension,
diabetes mellitus, and kidney disease. We also created interaction
terms with corresponding P-values in the statistical models.
Missing values for covariates, if present, occurred in <3% of the
cases, and were dealt with using multiple imputations with all
covariates of interest as predictors. We explored the possibility of
collinearity, given the Pearson correlation coefﬁcient between
arteriolar and venular diameter (r=0.53), by calculating the
variance inﬂation factor, but no collinearity was identiﬁed
(variance inﬂation factor <1.2). Statistical tests were performed
at the 0.05 level of signiﬁcance (two-tailed) using SPSS 21.0 for
Windows (IBM Corp., Armonk, NY).3. Results
The characteristics of the study population are reported in
Table 1. Of the total 5675 participants, 56% were women and
the average age was 60.1 years (SD=8.1). The average vitamin D
level was 60.8nmol/L (range=8–175nmol/L), and 40% of the
participants had vitamin D deﬁciency. Persons with retinopathy
had an average vitamin D level of 52.3nmol/L (SD=27.7), and
persons without retinopathy 61.2nmol/L (SD=28.1).
Table 2 shows the associations between vitamin D and the
presence of retinopathy. Lower levels of vitamin D were
signiﬁcantly associated with the presence of retinopathy: odds
ratio (OR) per SD decrease of vitamin D was 1.42 (95%
conﬁdence interval (CI)=1.21–1.66). This association attenuated3after adjusting for cardiovascular risk factors, but remained
statistically signiﬁcant (OR=1.28 (1.09–1.50)). Adjusted OR for
the presence of retinopathy was 1.62 (1.05–2.49) for persons in
the ﬁrst quartile of vitamin D compared with persons in the
fourth quartile.
Table 3 shows associations of vitamin D with retinal
microvascular calibers. We found that lower levels of vitamin
D were signiﬁcantly associated with wider venular calibers,
irrespective of cardiovascular risk factors: adjusted mean
difference per SD decrease of vitamin D was 1.37 (0.65–2.09).
On the other hand, lower vitaminD levels were weakly associated
with narrower arteriolar calibers: adjusted mean difference was
0.15 (0.32; 0.61).
Furthermore, the associations between vitamin D and
microvascular damage remained similar after adjusting for
vitamin supplement use, or excluding supplement users (n=
1343). Also, in RS-III, adjusting for vitamin D from food intake
attenuated the associations, but it remained statistically signiﬁ-
cant: adjusted OR for the presence of retinopathy was 1.58
(1.18–2.13), and adjusted mean difference for venular calibers
was 0.99 (0.14–1.83).
In stratiﬁed analyses (Table 4), we found that sex modiﬁed the
association of vitamin D with venules with a signiﬁcant p-value
for formal interaction term (P=0.023).4. Discussion
In this population-based study, we found that lower vitamin D
serum levels were associated with the presence of microvascular
damage, independent of cardiovascular risk factors.
Vitamin D has been widely recognized to play important in the
development of CVD, and investigators have repeatedly shown
that patients deﬁcient in vitamin D are more likely to develop
coronary heart disease,[23] stroke,[24] and cardiovascular mortal-
ity.[25] Despite robust evidence of vitamin D to be a risk factor for
[29]
Table 2
Associations between vitamin D and retinopathy.
Presence of retinopathy odds ratio (95% CI)
Vitamin D n/N Model 1 Model 2
Per SD decrease 264/5675 1.42 (1.21–1.66) 1.28 (1.09–1.50)
Quartiles (range)
4th quartile (79.2–175.0) 97/1414 1.00 (reference) 1.00 (reference)
3rd quartile (57.7–79.2) 72/1413 1.26 (0.87–1.81) 1.14 (0.78–1.65)
2nd quartile (38.8–57.6) 49/1431 2.13 (1.40–3.22) 1.79 (1.17–2.74)
1st quartile (7.5–38.8) 46/1417 2.07 (1.37–3.13) 1.62 (1.05–2.49)
P for trend <0.001 0.006
Vitamin D deﬁciency (50 nmol/L)
Absent 119/3396 1.00 (reference) 1.00 (reference)
Present 145/2279 1.86 (1.39–2.48) 1.54 (1.14–2.08)
Model 1: adjusted for age, sex, season, and subcohort.
Model 2: as model 1, additionally adjusted for systolic blood pressure, diastolic blood pressure, antihypertensive medication, lipid-lowering medication, body mass index, total cholesterol, high-density lipoprotein
cholesterol, diabetes mellitus, C-reactive protein, carotid plaque, estimated glomerular ﬁltration rate, and smoking.
CI= conﬁdence interval, n/N=number of persons with retinopathy among total number of persons, SD= standard deviation.
Table 3
Associations between vitamin D and retinal vascular calibers.
Arteriolar caliber, mean difference (95% CI) Venular caliber, mean difference (95% CI)
Vitamin D Model 1 Model 2 Model 1 Model 2
Per SD decrease 0.27 (0.75; 0.21) 0.15 (0.32; 0.61) 2.07 (1.36; 2.77) 1.37 (0.65; 2.09)
Quartiles
4th quartile (79.2–175.0) 0 (reference) 0 (reference) 0 (reference) 0 (reference)
3rd quartile (57.7–79.2) 0.47 (0.85; 1.77) 0.71 (0.54; 1.95) 0.74 (1.21; 2.69) 0.50 (1.45; 2.41)
2nd quartile (38.8–57.6) 0.35 (0.98; 1.67) 1.06 (0.21; 2.34) 2.77 (0.79; 4.74) 1.67 (0.28; 3.62)
1st quartile (7.5–38.8) 0.68 (2.00; 0.64) 0.44 (0.85; 1.73) 5.42 (3.46; 7.38) 3.58 (1.61; 5.55)
P for trend 0.300 0.433 <0.001 <0.001
Model 1: adjusted for age, sex, season, and the other vascular caliber.
Model 2: as model 1, additionally adjusted for systolic blood pressure, diastolic blood pressure, antihypertensive medication, lipid-lowering medication, body mass index, total cholesterol, high-density lipoprotein
cholesterol, diabetes mellitus, C-reactive protein, carotid plaque, estimated glomerular ﬁltration rate, and smoking.
CI= conﬁdence interval, SD= standard deviation.
Table 4
Stratiﬁed analyses for associations between serum vitamin D levels and retinal microvascular damage.
n/N
Presence of retinopathy
odds ratio (95% CI) per
SD decrease in vitamin D N
Venular caliber mean
difference (95% CI) per
SD decrease in vitamin D
Men 145/2518 1.34 (1.08; 1.66) 1275 2.38 (1.32; 3.45)
Women 119/3157 1.21 (0.94; 1.57) 1698 0.75 (0.22; 1.71)
Cardiovascular disease, yes 40/409 1.53 (0.88; 2.65) 184 0.80 (2.67; 4.27)
Cardiovascular disease, no 223/5241 1.25 (1.06; 1.49) 2771 1.33 (0.60; 2.07)
Hypertension, yes 187/3196 1.20 (0.98; 1.46) 1491 1.79 (0.74; 2.83)
Hypertension, no 77/2479 1.43 (1.07; 1.91) 1482 1.01 (0.02; 2.00)
Diabetes mellitus, yes 82/555 1.67 (1.16; 2.42) 247 2.72 (0.33; 5.78)
Diabetes mellitus, no 182/5120 1.18 (0.99; 1.42) 2726 1.24 (0.50; 1.98)
Kidney disease, yes 44/357 1.32 (0.93; 4.13) 102 1.73 (2.80; 6.26)
Kidney disease, no 220/5318 1.25 (1.05; 1.48) 2871 1.37 (0.64; 2.10)
n/N denotes the number of persons with retinopathy among total number of persons.
Adjusted for age, sex, season, the other vascular caliber, systolic blood pressure, diastolic blood pressure, antihypertensive medication, lipid-lowering medication, body mass index, total cholesterol, high-density
lipoprotein, diabetes mellitus, C-reactive protein, carotid plaque, estimated glomerular ﬁltration rate, and smoking.
CI= conﬁdence interval, n/N=number of persons with retinopathy among total number of persons, SD= standard deviation.
Mutlu et al. Medicine (2016) 95:49 MedicineCVD, exact mechanisms through which vitamin D leads to the
development of CVD remain unclear. Thus far, studies have
suggested that vitamin D affects cardiovascular health through its
association with cardiovascular risk factors such as diabetes
mellitus,[26] an unfavorable lipid proﬁle,[27] inﬂammation,[28]4and indices of large-vessel disease. Apart from these factors, it
has been suggested that vitamin D may act on cardiovascular
health through changes in the microvasculature. Given the
increasing importance of microvascular disease in the develop-
ment of CVD,[30] it is possible that the link between vitamin D
Mutlu et al. Medicine (2016) 95:49 www.md-journal.comand CVD may be explained by a microvascular component.
Indeed, recent studies have shown that vitamin D is associated
with nephropathy and with structural magnetic resonance
imaging (MRI) markers of microvascular disease in the brain,
that is, white matter lesions and lacunar infarcts.[15] Extending
these previous ﬁndings, the main novelty of our study is that we
show a link between vitamin D and direct visualization of
microvascular damage, as reﬂected by qualitative and quantita-
tive retinal parameters. Several explanations can be proposed for
the association of vitamin D with microvascular damage. First,
vitamin D may alter the structure and arrangement of
microvasculature by endothelium activation. Both in large-vessel
disease and in microvascular disease, endothelium is the key
component that initiates pathological vascular processes. As
such, vitamin D receptors (i.e., DNA-binding transcription
factors) expressed on endothelial cells modulate endothelial cell
function by binding to these receptors. Subsequently, the
activated endothelium promotes endothelial cell proliferation
and migration by stimulating the production of nitric oxide
production, and reducing the production of reactive oxygen
species.[31] It also inhibits innate inﬂammatory process by
modulating speciﬁc signaling pathways and reduces vascular
tone via the production of endothelium-derived contracting
factors.[32] Against this background, it is conceivable that these
antioxidative and vasodilatory processes may not be initiated in
case of low vitamin D levels, and therefore damage to the blood
vessels may occur. It is noteworthy to mention that in recent
years, apart from arterioles, the role of venules in CVDhas gained
attention, and converging evidence shows wider venules to be an
important marker for CVD. Also in our study, vitamin D was
particularly related to venules and not arterioles, which further
points toward the importance of venules in CVD. Given that both
lower vitamin D levels and wider venules are related to ischemia,
it is likely that vitamin D and venules are connected in the
pathways of ischemia.[33] How exactly these 2 factors are
connected should be investigated in further research.
Other potential mechanisms through which vitamin D could
lead to microvascular damage include inﬂammation, lipid
metabolism, and renin–angiotensin–aldosterone system, which
are all processes involved in the pathogenesis of arteriosclero-
sis.[29] In our study, adjusting for markers of these processes (e.g.,
C-reactive protein, cholesterol, and blood pressure) showed that
the associations between vitamin D and retinal microvascular
damage greatly attenuated, pointing further toward some effects
through these processes. However, the associations remained
statistically signiﬁcant, indicating that other processes likely also
play a role or that measurement error in covariates led to
insufﬁcient adjustment.
Several limitations need to be discussed. First, the cross-
sectional design of our analyses limits our ability to infer a
temporal link between vitamin D and retinal microvascular
damage. Another limitation is that retinal fundus photographs
were taken at a single time-point, and thus, we were unable to
measure dynamic measures synchronized on the cardiac cycle.
This may have caused random misclassiﬁcation, leading to an
underestimation of our associations. Third, we were not able to
measure important confounding factors such as (lifetime) sun-
exposure and food intake. These factors could confound the
effect of vitamin D on microvascular damage. Finally, partic-
ipants in the RS are mainly middle-class white persons, which
limits the generalizability of our ﬁndings. Strengths of our study
are the population-based setting, large study size, and the
extensive information on covariates.5In conclusion, lower vitamin D serum levels are associated with
the presence of retinal microvascular damage, suggesting that the
link with cardiovascular risk factor may partly run through
changes in the microvasculature.Acknowledgments
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